Metabolic dysfunction-associated steatohepatitis
NASHNET (MASHNET) is a US nonprofit network of 20+ academic medical centers across the US and Europe that convenes providers to define a standard of care for metabolic dysfunction-associated steatohepatitis (MASH) through research, education, and a cross-institutional patient registry.
- Company typePrivate
- Founded2016
- HeadquartersNew York, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Metabolic dysfunction-associated steatohepatitis does
NASHNET (also referred to as MASHNET) is a US-based nonprofit healthcare network founded in 2016 that convenes 20+ leading academic medical centers and health systems across the United States and Europe to define and spread a standard of care for metabolic dysfunction-associated steatohepatitis (MASH). Named member institutions include Boston Medical Center, Cedars Sinai, Duke Health, Mount Sinai, NYU Langone, UPMC, Northwestern Medicine, and Weill Cornell Medicine, giving the network coverage of major US hepatology centers plus European partners. The organization does not operate a proprietary software platform; its core assets are the member community, shared educational content (webinars, toolkits, white papers, best practice sharing series), and coordinated research and data initiatives including a cross-institutional patient registry and real-world evidence studies.
The network's primary initiatives — Real-World Evidence Studies, Patient Registry & Data Analytics, Patient & Provider Education, and invite-only pilot/study opportunities — are delivered through a member portal and an active program of community workshops and events. A dedicated MASLD Diagnostic Coalition extends the network's scope upstream into diagnostic pathway standardization. The business model is membership-based, with health systems, group practices, and healthcare leaders paying dues for access to networking, pilots, data, and educational resources; an industry partner track extends the revenue base beyond provider members.
The go-to-market is community-led: prospective members apply through the website, are screened, and onboarded via an intro call, while the network uses content marketing, webinars, events, and referral workshops to attract new members and partners. There is no disclosed revenue, funding, or institutional investor base; the organization is described as operating independently with no parent company and no venture or private equity involvement.
Metabolic dysfunction-associated steatohepatitis firmographics
Firmographics- Name
- Metabolic dysfunction-associated steatohepatitis
- Website
- https://nashnetwork.org
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- NASHNET (MASHNET) is a US nonprofit network of 20+ academic medical centers across the US and Europe that convenes providers to define a standard of care for metabolic dysfunction-associated steatohepatitis (MASH) through research, education, and a cross-institutional patient registry.
- Ownership category
- akta.pro rank
Metabolic dysfunction-associated steatohepatitis industry classification
Industry- Product category
- Healthcare Professional Network
- SIC
- Services-Health Services (8000), Services-Membership Organizations (8600)
- akta.pro primary industry
- Primary Care Networks, Groups & MSOs (HLAFAGAE)
Keywords
Where Metabolic dysfunction-associated steatohepatitis is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Markets served
Metabolic dysfunction-associated steatohepatitis business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D
Revenue model
- Health System Membership: Health systems pay to join the network to gain access to exclusive networking opportunities, members-only resources, real-world evidence studies, pilot/study opportunities, patient registry & data analytics, and patient & provider education initiatives.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels7 records
Metabolic dysfunction-associated steatohepatitis product offering
Product offeringCore offering
NASHNET operates a membership-based network of 20+ health system partners across the US and Europe that collaborate on MASH (formerly NASH) care delivery innovation. Member health systems pay recurring fees to access exclusive networking opportunities, invite-only pilot/study opportunities, real-world evidence studies, a patient registry & data analytics program, patient & provider education, and a member portal with a resource library.
Product overview
MASHNET is a healthcare professional network, not a software product company. It operates as a multi-disciplinary network of 20+ health system partners across the US and Europe, including organizations like Boston Medical Center, Cedars Sinai, Duke Health, NYU Langone, and UPMC. The organization provides a platform for collaboration through initiatives including Real-World Evidence Studies, Patient Registry & Data Analytics, and Patient & Provider Education. Members gain access to exclusive networking opportunities, invite-only pilot/study opportunities, and a member portal with resources. The network also offers educational programs including Best Practice Sharing Series, Webinars, Toolkits, and Publications & White Papers, along with a MASLD Diagnostic Coalition. These offerings are designed to accelerate MASH care delivery innovation across the global healthcare community.
Differentiator
Problem solved
Functional benefit
Products and services
- MASHNET Health System Membership A recurring membership subscription for health systems and healthcare leaders that grants access to a multi-disciplinary network of 20+ Centers of Excellence across the US and Europe, exclusive networking, invite-only pilot/study opportunities, the NASHNET Member Portal & Resource Library, and participation in real-world evidence studies, patient registry and data analytics, and patient and provider education initiatives.
Companies that use Metabolic dysfunction-associated steatohepatitis
Customer profileNamed customers12 records
Segments2 records
Ideal customer profiles2 records
Metabolic dysfunction-associated steatohepatitis technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Metabolic dysfunction-associated steatohepatitis partnerships and signals
Strategic signalPartnerships
Twelve partnerships are on record, tiered core.
- Boston Medical CentercoreMember health system of the NASHNET Centers of Excellence Network. Boston Medical Center participates in real-world evidence studies, patient registry and data analytics, and contributes to defining best practices for MASH care delivery.
- Cedars SinaicoreMember health system of the NASHNET Centers of Excellence Network. Cedars Sinai contributes to the network's mission of creating a standard of care for MASH.
- Central Virginia VA Health Care SystemcoreMember health system of the NASHNET Centers of Excellence Network representing the VA healthcare system in MASH care delivery innovation.
- Duke HealthcoreMember health system of the NASHNET Centers of Excellence Network contributing to multi-disciplinary expert team and care delivery innovation.
- Methodist Dallas Medical CentercoreMember health system of the NASHNET Centers of Excellence Network participating in patient registry and data analytics initiatives.
- Mount SinaicoreMember health system of the NASHNET Centers of Excellence Network contributing to the global network of MASH care delivery innovation.
- Northwestern MedicinecoreMember health system of the NASHNET Centers of Excellence Network participating in best practice development for MASH care.
- NYU Langone HealthcoreMember health system of the NASHNET Centers of Excellence Network contributing to real-world evidence studies and pilot opportunities.
- Rush University Medical CentercoreMember health system of the NASHNET Centers of Excellence Network participating in care delivery innovation initiatives.
- Oregon Health Sciences University (OHS)coreMember health system of the NASHNET Centers of Excellence Network contributing to patient and provider education initiatives.
- UPMCcoreMember health system of the NASHNET Centers of Excellence Network participating in the network's research and education initiatives.
- Weill Cornell MedicinecoreMember health system of the NASHNET Centers of Excellence Network contributing to defining and spreading the best practice model for NASH care delivery.
Scale indicators2 records
Recent moves5 records
Expansion highlights4 records
Metabolic dysfunction-associated steatohepatitis competitors and assessment
Company assessmentBroad incumbents
- AMGA (American Medical Group Association): AMGA is a membership association of large multispecialty medical groups and health systems focused on performance improvement, data benchmarking, and best-practice sharing. It operates the same network/MSO model as NASHNET but across all conditions rather than MASH specifically.
- American College of Cardiology (ACC): ACC operates a Centers-of-Excellence-style network and registry infrastructure (e.g., NCDR) for cardiovascular care — an analogous disease-specific care-delivery and data-collection model that could serve as a template (or competitor framework) for MASH.
- Premier Inc. Premier is a large healthcare improvement company with a member network of hospitals and health systems that collaborates on analytics, supply chain, and performance improvement. It represents a much larger, well-capitalized version of NASHNET's health-system-collaboration model.
Direct peers
- American Liver Foundation: A national nonprofit focused on liver disease education, advocacy, and research funding — overlapping with NASHNET's patient/provider education mission in the same disease space, though operating at a national awareness rather than clinical-care-coordination layer.
- Global Liver Institute: A patient-centered liver disease advocacy and policy organization that convenes clinicians, patients, and policymakers. It parallels NASHNET's mission to standardize care and educate providers, applied across the broader liver disease continuum.
- National Comprehensive Cancer Network (NCCN): NCCN operates a near-identical model — a membership-based alliance of leading academic cancer centers that defines standards of care, runs guidelines, and produces real-world evidence. It is the closest structural analog to NASHNET's Centers-of-Excellence approach, applied to oncology instead of MASH.
- International Liver Transplantation Society (ILTS): ILTS is a global, multidisciplinary professional society focused on liver transplantation and end-stage liver disease, convening centers of excellence and running educational programming. It overlaps with NASHNET's model of expert-led, center-based collaboration in liver disease.
- Chronic Liver Disease Foundation: A nonprofit focused on advancing education, research, and clinical care for chronic liver disease, including NAFLD/NASH. It overlaps with NASHNET's care-delivery innovation, education, and best-practice dissemination activities for the same patient population.
- American Association for the Study of Liver Diseases (AASLD): AASLD is the dominant US professional society for hepatology, convening liver experts, publishing practice guidance, and running educational programming. NASHNET competes for mindshare and member engagement in the same MASH/NASH clinical community.
Regional players
- European Association for the Study of the Liver (EASL): EASL is the leading European hepatology society, performing an analogous convening and guideline role in the EU. NASHNET's stated EU expansion plan means it will increasingly compete with EASL for European center participation in MASH initiatives.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks4 records
Key highlights6 records
Customer concentration
Metabolic dysfunction-associated steatohepatitis social profiles
Digital presenceMetabolic dysfunction-associated steatohepatitis financial estimates
Financial estimateRevenue estimate
Valuation estimate
Metabolic dysfunction-associated steatohepatitis leadership team
Management profileNumber of profiles
Metabolic dysfunction-associated steatohepatitis funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Metabolic dysfunction-associated steatohepatitis M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Metabolic dysfunction-associated steatohepatitis
What does Metabolic dysfunction-associated steatohepatitis do?
NASHNET operates a membership-based network of 20+ health system partners across the US and Europe that collaborate on MASH (formerly NASH) care delivery innovation. Member health systems pay recurring fees to access exclusive networking opportunities, invite-only pilot/study opportunities, real-world evidence studies, a patient registry & data analytics program, patient & provider education, and a member portal with a resource library.
Is Metabolic dysfunction-associated steatohepatitis a public or private company?
Metabolic dysfunction-associated steatohepatitis is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Metabolic dysfunction-associated steatohepatitis founded?
Metabolic dysfunction-associated steatohepatitis was founded in 2016. It employs 11 to 50 people.
Where is Metabolic dysfunction-associated steatohepatitis based?
Metabolic dysfunction-associated steatohepatitis is headquartered in New York, United States, in the North America region.
How does Metabolic dysfunction-associated steatohepatitis make money?
One revenue line is on record: health System Membership.
Who are Metabolic dysfunction-associated steatohepatitis's main competitors?
Broad incumbents on record are AMGA (American Medical Group Association), American College of Cardiology (ACC) and Premier Inc.. Direct peers are American Liver Foundation, Global Liver Institute, National Comprehensive Cancer Network (NCCN), International Liver Transplantation Society (ILTS), Chronic Liver Disease Foundation and American Association for the Study of Liver Diseases (AASLD). European Association for the Study of the Liver (EASL) is listed as a regional player.
Does Metabolic dysfunction-associated steatohepatitis have an API?
No public API is recorded for Metabolic dysfunction-associated steatohepatitis.
What industry is Metabolic dysfunction-associated steatohepatitis in?
Metabolic dysfunction-associated steatohepatitis's product category is Healthcare Professional Network. Its primary akta.pro industry code is HLAFAGAE, Primary Care Networks, Groups & MSOs. Its SIC code is 8000.